The short answer
This page explains what invasive ductal carcinoma means on a breast biopsy pathology report, and what other results on the report tell your team. It is general education, not individual medical advice.
Invasive ductal carcinoma begins in the cells that line the milk ducts and has spread beyond where it first formed into nearby breast tissue.
It is the most common breast cancer diagnosis, so this report term is one pathologists write every day.
Invasive is different from in situ: DCIS stays inside the milk ducts, while invasive cancer has grown into surrounding tissue.
The rest of the report, including grade and hormone receptor and HER2 results, guides which treatments are likely to work.
Choose how you want to understand this
The full explanation.
Invasive ductal carcinoma is the most common phrase to find on a breast biopsy report, because it is the most common breast cancer diagnosis. The words sound frightening, and "invasive" is the one that lands hardest. On a pathology report it has a narrow, technical meaning, and knowing it makes the rest of the report easier to read.
Taking the term apart
Each word does a specific job.
Ductal names the starting point. This cancer begins in the cells that line the milk ducts, the thin tubes that carry milk toward the nipple.
Carcinoma is the kind of cancer, one that starts in the cells lining an organ or tissue.
Invasive describes behavior, not distance. NCI's definition is that the cancer has spread beyond where it first formed, meaning cells have grown through the duct lining into the surrounding breast tissue. It does not say anything about the rest of the body. Whether cancer has reached lymph nodes or organs is a separate question, answered by staging tests that come after the biopsy. NCI is direct that knowing the stage is what allows your team to plan treatment.
You may also see the name written as infiltrating ductal carcinoma. Same meaning.
Invasive versus in situ: the DCIS line
The clearest way to understand "invasive" is by its opposite. In ductal carcinoma in situ, or DCIS, abnormal cells form in the lining of the milk ducts but have not broken out of the ducts into other breast tissue. NCI notes DCIS may also be called noninvasive breast cancer, intraductal carcinoma, or stage 0 breast cancer, and describes it as precancer because it may become invasive later.
So the duct wall is the boundary the pathologist is reporting on. Cells confined inside it: in situ. Cells that have crossed it: invasive. Some reports show both on the same slide, an invasive cancer with areas of DCIS beside it. The invasive part drives the treatment plan. Our pages on in situ versus invasive cancer and DCIS go further.
For scale: NCI notes that DCIS alone accounts for about 20 to 25 percent of new breast cancer cases each year, and most DCIS is found on a screening mammogram. Invasive ductal carcinoma is the most common invasive type.
The other ductal question: lobular
The second common invasive type starts one station over. Invasive lobular carcinoma begins in the cells lining the lobules, the glands that make milk. NCI notes it grows more slowly than invasive ductal carcinoma, is less common, and is more often found in both breasts than other types. If your report says ductal, it is describing where your cancer began, not how serious it is.
What else the report adds
"Invasive ductal carcinoma" is the headline, but the working details come from the rest of the report and from biomarker tests. NCI lists what the pathology report covers: where in the breast the cancer started, the tumor grade, and whether the cancer has spread into nearby normal tissue.
Grade describes how abnormal the cells look under a microscope and how quickly they are likely to grow and spread, scored from 1, least abnormal, to 3, most abnormal.
Hormone receptors. Breast cancer cells are tested for estrogen and progesterone receptors, which tell cells to grow when those hormones are present. When cancer cells have these receptors, the hormones can fuel cancer growth, and hormone therapy that blocks or interferes with them is often an option. Hormone receptor negative cancers probably will not respond to hormone-blocking treatment, so other options such as chemotherapy are used.
HER2 is a protein that helps control breast cell growth. HER2-positive cancers are more likely to be fast growing, and HER2 status helps determine whether drugs that target HER2 will help.
Two people with "invasive ductal carcinoma" on their reports can have very different cancers and very different plans once grade, receptors, and stage are known. That is why the phrase alone cannot tell you your outlook.
What happens next
After the biopsy confirms invasive cancer, your team orders staging tests and biomarker analysis, then builds a plan around the full picture. Bring the report to your visit and ask your team to walk through it line by line. Every term on it was written to be used, and you are allowed to understand all of them.
Sources
Words to know
Tap any term to see what it means.
Common questions
Does invasive mean my cancer has spread through my body?
No. On a breast pathology report, invasive means the cancer has spread beyond where it first formed, out of the milk duct and into nearby breast tissue. Whether it has traveled anywhere else is a separate question, answered by staging tests. NCI notes that knowing the stage is what lets your team plan treatment.
How common is invasive ductal carcinoma?
NCI describes invasive ductal carcinoma as the most common breast cancer diagnosis. It begins in the cells that line the milk ducts. The second pattern, invasive lobular carcinoma, starts in the milk-making glands called lobules, grows more slowly, and is less common.
What is the difference between IDC and DCIS?
Both start in the milk ducts. In DCIS, abnormal cells form in the lining of the milk ducts but have not broken out of the ducts. In invasive ductal carcinoma, the cells have spread beyond the duct into surrounding tissue. NCI notes DCIS may also be called noninvasive breast cancer or stage 0.
What does tumor grade mean on my report?
NCI explains that tumor grade describes how abnormal the cancer cells and tissue look under a microscope, and how quickly the cells are likely to grow and spread. For breast cancer, scores run from 1, least abnormal, to 3, most abnormal. Grade is one input among several; your team reads it together with stage and biomarker results.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Plain-language definitions for the words on your report.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-21 what this meansLast updated: 2026-08-21Next planned review: 2027-08-21
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share